©The Author(s) 2026.
World J Gastroenterol. Feb 14, 2026; 32(6): 113010
Published online Feb 14, 2026. doi: 10.3748/wjg.v32.i6.113010
Published online Feb 14, 2026. doi: 10.3748/wjg.v32.i6.113010
Figure 4 Fecal deoxycholic acid levels in mice and inflammatory factor expression in colonic tissue.
A: Fecal deoxycholic acid content of mice in each group; B-D: Expression levels of interleukin-1β, tumour necrosis factor alpha, and interleukin-4 in mouse colonic tissue. n = 6. aP < 0.05, bP < 0.01, and cP < 0.001. DCA: Deoxycholic acid; TNF-α: Tumour necrosis factor alpha; IL: Interleukin; H-V-D-S: High-fat diet with vancomycin, deoxycholic acid, and Bifidobacterium; H-V-D: High-fat diet with vancomycin and deoxycholic acid; H-V-S: High-fat diet with vancomycin and Bifidobacterium; H-V: High-fat diet with vancomycin; H-S: High-fat diet supplemented with Bifidobacterium; H: High-fat diet; N: General.
- Citation: Yang PC, Xiao CY, Wang J, Yan CH, Li QY, Li SY, Li J, Zhang LJ, Dai CB. Effects and mechanism of Bifidobacterium on intestinal inflammation resulting from deoxycholic acid-induced M1 polarization of macrophages. World J Gastroenterol 2026; 32(6): 113010
- URL: https://www.wjgnet.com/1007-9327/full/v32/i6/113010.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i6.113010